Somatic mutation of PTEN is seen in
First, the core concept here is PTEN mutations. PTEN is a tumor suppressor gene. Somatic mutations in tumor suppressor genes are associated with various cancers. PTEN is involved in the PI3K/AKT/mTOR pathway, which regulates cell growth and survival. When PTEN is mutated, this pathway becomes hyperactive, leading to uncontrolled cell proliferation.
Now, which diseases are linked to PTEN mutations? I recall that PTEN mutations are found in certain cancers. For example, Cowden syndrome is a hereditary condition caused by germline PTEN mutations, leading to hamartomas and increased cancer risk. But the question is about somatic mutations. Somatic PTEN mutations are seen in endometrial cancer, glioblastoma, and maybe breast or prostate cancers. Wait, I think endometrial cancer is a common one. Let me confirm: studies show that PTEN mutations are frequent in endometrioid endometrial carcinomas. Glioblastomas also have PTEN mutations. So if the options included endometrial cancer, that would be correct. If the options included glioblastoma, that's also possible. But the user hasn't provided the actual options here. Hmm, maybe the original question had options like A. Breast cancer B. Colorectal cancer C. Endometrial cancer D. Glioblastoma. Then the correct answer would be C and D. But since the user didn't list the options, I need to proceed with the assumption that the correct answer is endometrial cancer or glioblastoma.
For the explanation, the core concept is PTEN's role in tumor suppression. The correct answer explanation would detail how PTEN mutations lead to loss of function, activating the PI3K/AKT pathway. For the incorrect options, each would be another cancer not typically associated with PTEN mutations. For example, if an option was colon cancer, PTEN mutations are less common there compared to endometrial. The clinical pearl would be remembering that PTEN mutations are key in endometrial and glioblastoma cancers, and targeting the mTOR pathway is a treatment approach.
But since the user's example answer is structured with specific sections, I need to follow that. Let me structure the answer accordingly. The core concept is PTEN's role as a tumor suppressor gene. The correct answer is likely endometrial cancer. The incorrect options would be other cancers. The clinical pearl would be to remember endometrial and glioblastoma as key associations.
**Core Concept**
PTEN (Phosphatase and Tensin Homolog) is a tumor suppressor gene that negatively regulates the PI3K/AKT/mTOR signaling pathway. Somatic mutations in PTEN lead to pathway hyperactivation, promoting uncontrolled cell proliferation and tumorigenesis.
**Why the Correct Answer is Right**
Somatic PTEN mutations are most commonly associated with **endometrioid endometrial carcinoma**, occurring in ~30-50% of cases. Loss of PTEN function increases phosphoinositide signaling, driving cell survival and resistance to apoptosis. This mutation is a hallmark of the